Indication

Protein C deficiency disease

Protein C deficiency is a rare congenital or acquired thrombophilic disorder of the hematologic and vascular systems caused by reduced levels or impaired function of the natural anticoagulant protein C. Read more about Protein C deficiency disease

9 drugs 4 manufacturers

Advertisement

Drugs that treat it

Common Protein C deficiency disease therapies.

Showing 1–9 of 9 drugs

Filter & compare in the drug finder →Opens the drug finder with Protein C deficiency disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Protein C deficiency disease.

Protein C deficiency is a rare congenital or acquired thrombophilic disorder of the hematologic and vascular systems caused by reduced levels or impaired function of the natural anticoagulant protein C.

Because activated protein C normally cleaves and inactivates activated factors V and VIII, this deficiency leads to unregulated thrombin generation and a heightened propensity for abnormal clotting.

Clinically, mild forms—frequently seen in heterozygous individuals—predominantly manifest in adulthood as recurrent venous thromboembolism, such as deep vein thrombosis and pulmonary embolism.

In contrast, severe forms in homozygous or compound heterozygous neonates present shortly after birth with life-threatening neonatal purpura fulminans characterized by microvascular thrombosis, widespread tissue necrosis, and disseminated intravascular coagulation.

Personalize your experience

Follow Protein C deficiency disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it